TENAX THERAPEUTICS, INC. Annual Operating Income (Loss) in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Tenax Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2023.
  • Tenax Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $4.62M, a 118% increase year-over-year.
  • Tenax Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $10.8M, a 147% increase year-over-year.
  • Tenax Therapeutics, Inc. annual Operating Income (Loss) for 2023 was $8.23M, a 25.5% decline from 2022.
  • Tenax Therapeutics, Inc. annual Operating Income (Loss) for 2022 was $11.1M.
  • Tenax Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$32.7M, a 432% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $8.23M -$2.82M -25.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $11.1M +$43.8M Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 -$32.7M -$42.6M -432% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $9.87M +$18.4M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 -$8.56M -$1.66M -24.1% Jan 1, 2019 Dec 31, 2019 10-K/A 2021-04-16
2018 -$6.89M +$2.31M +25.1% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$9.21M +$43.4M +82.5% Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2016 -$52.7M Jan 1, 2016 Dec 31, 2016 10-K 2018-04-02
2014 -$14.8M +$1.79M +10.8% May 1, 2014 Apr 30, 2015 10-K 2017-03-16
2013 -$16.6M -$11.4M -220% May 1, 2013 Apr 30, 2014 10-K 2017-03-16
2012 -$5.19M +$3.03M +36.9% May 1, 2012 Apr 30, 2013 10-KT 2016-03-14
2011 -$8.22M -$18.8M -178% May 1, 2011 Apr 30, 2012 10-K 2013-06-26
2010 $10.6M May 1, 2010 Apr 30, 2011 10-K 2012-07-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.